Mesothelioma, Malignant

SW-682 in Advanced Solid Tumors

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma

A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

......SMARTEST Trial......

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

HTL0039732 in Participants With Advanced Solid Tumours

A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma

Niraparib Efficacy in Patient With Unresectable Mesothelioma

First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.

A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies